BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that Robert Connelly, Chief Executive Officer, and Pete DeMuth, PhD, Chief Scientific Officer, will participate in the upcoming TD Cowen 46th Annual Health Care Conference, taking place March 2-4, 2026, in Boston, MA. TD Cowen 46th Annual Health Care ConferenceFormat: ...

SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- WillScot (Nasdaq: WSC), the industry leader in modular building and storage solutions, today announced that its fencing and perimeter‑security offering is now available nationwide, marking a significant milestone for the Company and reflecting the rapid scale‑up of RentaFence.com across the U.S. “Expanding our fencing offering nationally strengthens our ability to support customers from the very start of their projects,” said Tim Boswell, President and Ch ...

PHILADELPHIA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes, and cancer, today announced that the company will participate in the following upcoming investor conferences in March: TD Cowen 46th Annual Health Care Conference: Fireside chat at 9:50 a.m. ET on Wednesday, March 4, 2026, in Boston, MA. Leerink Partners Global H ...

RIDGEFIELD, Conn., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today announced that the Company will participate in a fireside chat at the UBS Global Consumer & Retail Conference in New York, NY on Wednesday, March 11, 2026. The fireside chat will begin at 9:00 a.m. ET. Investors and interested parties may listen to a webcast of the fireside chat by ...

Taipei, Taiwan, Feb. 25, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that its subsidiary YD Bio USA, Inc. (“YD Bio USA”) entered into a Master Strategic Alliance Agreement (the “Agreement”) with YC Biotech Co., Ltd. (“YC Biotech”) on February 24, 2026. This partnership represents a pivotal advancement in the Company’s mission, establi ...

SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leader in defense, national security and global markets, announced today that it has been awarded a $61,068,139 modification to a previously awarded firm-fixed-price contract (N0001923C0021) by the U.S. Navy. This contract modification exercises options to procure full-rate production Lot Seven for 70 of the BQM-177A Subsonic Aerial Targets, along with 70 Rocket-Assisted Takeoff (RATO) attachment kits an ...

Company Completes GMP Pilot for Phyto-N, Targets Ulcerative Colitis IND Submission Q4 2026 Jericho, New York, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a development-stage pharmaceutical company focused on the discovery and development of botanical drugs for the treatment of inflammatory diseases, today announced the completion of a Good Manufacturing Practice (GMP)-compliant pilot-scale batch of its lead botanical drug candidate, Phyto-N. Th ...

CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor conferences in March. Details for the conferences are as follows: Jefferies Healthcare Services Innovation & Technology SummitPresentation: Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ETLocation: Miami, FLPresenter: Dr. Daniel Virnich, Chief Executive Office ...

Reduced headcount from 350 to 84, including 12+% this quarterEliminated ~$14M in liabilities, repaying $3M of debt and converting $11M+ into equity at $7.50 per share, aligning musicians, podcasters, and key talent as major shareholders while strengthening the balance sheet LOS ANGELES, Feb. 25, 2026 (GLOBE NEWSWIRE) -- LiveOne, Inc. (Nasdaq: LVO), a creator-first music, entertainment and technology platform, today announced continued execution of its strategic cost-reduction initiatives expected to strengt ...

ST. LOUIS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) announced the appointments of Thomas Turner and Xiaofeng "Frank" Yao to its Board of Directors, effective as of February 20, 2026. About Thomas Turner Turner currently serves as Senior Managing Director at CVC Capital Partners (U.S.) Inc., where he has been a member of the Capital Markets team since September 2022. Prior to CVC, Turner held Managing Director roles at Apollo Global Management, Inc. and Bank of America Merrill ...